home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Cancer - Principles & Practice of Oncology
/
Oncology.iso
/
PPO
/
CHAP35
/
F5_7B.CAP
< prev
next >
Wrap
Text File
|
1999-06-07
|
301b
|
6 lines
FIGURE 35.5-7B. Overall survival of patients with suboptimal stage III
and IV ovarian cancer randomized to treatment with cisplatin plus
cyclophosphamide (solid line) or cisplatin plus paclitaxel (dotted
line). (McGuire WP, Hoskins WJ, Brody MF, et al. N Engl J Med
1996;334:1)